These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11696357)

  • 1. GSK-3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and beta-catenin stabilisation without elevation of glycogen synthase activity.
    Culbert AA; Brown MJ; Frame S; Hagen T; Cross DA; Bax B; Reith AD
    FEBS Lett; 2001 Nov; 507(3):288-94. PubMed ID: 11696357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death.
    Cross DA; Culbert AA; Chalmers KA; Facci L; Skaper SD; Reith AD
    J Neurochem; 2001 Apr; 77(1):94-102. PubMed ID: 11279265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription.
    Coghlan MP; Culbert AA; Cross DA; Corcoran SL; Yates JW; Pearce NJ; Rausch OL; Murphy GJ; Carter PS; Roxbee Cox L; Mills D; Brown MJ; Haigh D; Ward RW; Smith DG; Murray KJ; Reith AD; Holder JC
    Chem Biol; 2000 Oct; 7(10):793-803. PubMed ID: 11033082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A GSK3-binding peptide from FRAT1 selectively inhibits the GSK3-catalysed phosphorylation of axin and beta-catenin.
    Thomas GM; Frame S; Goedert M; Nathke I; Polakis P; Cohen P
    FEBS Lett; 1999 Sep; 458(2):247-51. PubMed ID: 10481074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The B cell antigen receptor regulates the transcriptional activator beta-catenin via protein kinase C-mediated inhibition of glycogen synthase kinase-3.
    Christian SL; Sims PV; Gold MR
    J Immunol; 2002 Jul; 169(2):758-69. PubMed ID: 12097378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of glycogen synthase kinase activity is not sufficient for leukemia enhancer factor-1 activation.
    Yuan H; Mao J; Li L; Wu D
    J Biol Chem; 1999 Oct; 274(43):30419-23. PubMed ID: 10521419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of glycogen synthase kinase 3beta and downstream Wnt signaling by axin.
    Hedgepeth CM; Deardorff MA; Rankin K; Klein PS
    Mol Cell Biol; 1999 Oct; 19(10):7147-57. PubMed ID: 10490650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lithium inhibits neurite growth and tau protein kinase I/glycogen synthase kinase-3beta-dependent phosphorylation of juvenile tau in cultured hippocampal neurons.
    Takahashi M; Yasutake K; Tomizawa K
    J Neurochem; 1999 Nov; 73(5):2073-83. PubMed ID: 10537067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of glycogen synthase kinase-3 represses androgen receptor activity and prostate cancer cell growth.
    Mazor M; Kawano Y; Zhu H; Waxman J; Kypta RM
    Oncogene; 2004 Oct; 23(47):7882-92. PubMed ID: 15361837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin.
    Ikeda S; Kishida S; Yamamoto H; Murai H; Koyama S; Kikuchi A
    EMBO J; 1998 Mar; 17(5):1371-84. PubMed ID: 9482734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation.
    Bax B; Carter PS; Lewis C; Guy AR; Bridges A; Tanner R; Pettman G; Mannix C; Culbert AA; Brown MJ; Smith DG; Reith AD
    Structure; 2001 Dec; 9(12):1143-52. PubMed ID: 11738041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice.
    Lucas JJ; Hernández F; Gómez-Ramos P; Morán MA; Hen R; Avila J
    EMBO J; 2001 Jan; 20(1-2):27-39. PubMed ID: 11226152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin.
    Ikeda S; Kishida M; Matsuura Y; Usui H; Kikuchi A
    Oncogene; 2000 Jan; 19(4):537-45. PubMed ID: 10698523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tcf-1-mediated transcription in T lymphocytes: differential role for glycogen synthase kinase-3 in fibroblasts and T cells.
    Staal FJ; Burgering BM; van de Wetering M; Clevers HC
    Int Immunol; 1999 Mar; 11(3):317-23. PubMed ID: 10221643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axin and Frat1 interact with dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1.
    Li L; Yuan H; Weaver CD; Mao J; Farr GH; Sussman DJ; Jonkers J; Kimelman D; Wu D
    EMBO J; 1999 Aug; 18(15):4233-40. PubMed ID: 10428961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of ribosomal S6 protein kinase-p90(rsk), glycogen synthase kinase 3, and beta-catenin in early Xenopus development.
    Torres MA; Eldar-Finkelman H; Krebs EG; Moon RT
    Mol Cell Biol; 1999 Feb; 19(2):1427-37. PubMed ID: 9891076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription.
    Sakanaka C; Weiss JB; Williams LT
    Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3020-3. PubMed ID: 9501208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the Wnt signaling pathway: a molecular mechanism for lithium action.
    Hedgepeth CM; Conrad LJ; Zhang J; Huang HC; Lee VM; Klein PS
    Dev Biol; 1997 May; 185(1):82-91. PubMed ID: 9169052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt signaling to beta-catenin involves two interactive components. Glycogen synthase kinase-3beta inhibition and activation of protein kinase C.
    Chen RH; Ding WV; McCormick F
    J Biol Chem; 2000 Jun; 275(23):17894-9. PubMed ID: 10749878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of the phosphorylation of beta-catenin at the GSK-3 priming site Ser45.
    Hagen T; Vidal-Puig A
    Biochem Biophys Res Commun; 2002 Jun; 294(2):324-8. PubMed ID: 12051714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.